Found: 10
Select item for more details and to access through your institution.
Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia.
- Published in:
- BioDrugs, 2023, v. 37, n. 2, p. 219, doi. 10.1007/s40259-023-00583-9
- By:
- Publication type:
- Article
Consistency of Product Quality for SB5, an Adalimumab Biosimilar.
- Published in:
- BioDrugs, 2023, v. 37, n. 2, p. 271, doi. 10.1007/s40259-023-00581-x
- By:
- Publication type:
- Article
Targeting the Inside of Cells with Biologicals: Toxin Routes in a Therapeutic Context.
- Published in:
- BioDrugs, 2023, v. 37, n. 2, p. 181, doi. 10.1007/s40259-023-00580-y
- By:
- Publication type:
- Article
Copies of Biological Medicines: Similar But Not the Same?
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Retention Rate and Safety of Biologic and Targeted Synthetic DMARDs in Patients with RA-Associated Interstitial Lung Disease: A KOBIO Registry Study.
- Published in:
- BioDrugs, 2023, v. 37, n. 2, p. 247, doi. 10.1007/s40259-023-00578-6
- By:
- Publication type:
- Article
RNA Targeting and Gene Editing Strategies for Transthyretin Amyloidosis.
- Published in:
- BioDrugs, 2023, v. 37, n. 2, p. 127, doi. 10.1007/s40259-023-00577-7
- By:
- Publication type:
- Article
Comparative Safety Profiles of Oncology Biosimilars: A Systematic Review and Network Meta-analysis.
- Published in:
- BioDrugs, 2023, v. 37, n. 2, p. 205, doi. 10.1007/s40259-023-00576-8
- By:
- Publication type:
- Article
Current Progress and Challenges in the Study of Adjuvants for Oral Vaccines.
- Published in:
- BioDrugs, 2023, v. 37, n. 2, p. 143, doi. 10.1007/s40259-022-00575-1
- By:
- Publication type:
- Article
Efficacy and Safety of Denosumab Biosimilar QL1206 Versus Denosumab in Patients with Bone Metastases from Solid Tumors: A Randomized Phase III Trial.
- Published in:
- BioDrugs, 2023, v. 37, n. 2, p. 259, doi. 10.1007/s40259-023-00579-5
- By:
- Publication type:
- Article
The Global Landscape of Manufacturers of Follow-on Biologics: An Overview of Five Major Biosimilar Markets and 15 Countries.
- Published in:
- BioDrugs, 2023, v. 37, n. 2, p. 235, doi. 10.1007/s40259-022-00568-0
- By:
- Publication type:
- Article